Application
Fig1: Western blot analysis of ZFP91 on ?human ZFP91 recombinant protein using anti-ZFP91 antibody at 1/1,000 dilution.
Application
Fig2: Western blot analysis of ZFP91 on HEK293 (1) and ZFP91-hIgGFc transfected HEK293 (2) cell lysate using anti-ZFP91 antibody at 1/1,000 dilution.
Application
Fig3: Western blot analysis of ZFP91 on different cell lysate using anti-ZFP91 antibody at 1/1,000 dilution. Positive control: Lane1: Jurkat Lane2: A431 Lane3: HepG2 Lane4: HEK293 Lane5: A549 Lane6:PC-3
Application
Fig4:ICC staining ZFP91 (green) and Actin filaments (red) in Hela cells. The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.
Application
Fig5: Immunohistochemical analysis of paraffin-embedded human ovarian cancer tissue using anti-ZFP91 antibody. Counter stained with hematoxylin.
Application
Fig6: Immunohistochemical analysis of paraffin-embedded human ?rectum cancer tissue using anti-ZFP91 antibody. Counter stained with hematoxylin.
Application
Fig7:Flow cytometric analysis of Hela cells with ZFP91 antibody at 1/100 dilution (green) compared with an unlabelled control (cells without incubation with primary antibody; red).